Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation

von Clarke, William T
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2018)